Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 1990. Upgrade now.
Date Value
September 30, 2024 -3.852B
June 30, 2024 -4.023B
March 31, 2024 14.64B
December 31, 2023 967.00M
September 30, 2023 -5.16B
June 30, 2023 -2.173B
March 31, 2023 -3.05B
December 31, 2022 -3.246B
September 30, 2022 -4.543B
June 30, 2022 -3.52B
March 31, 2022 -5.653B
December 31, 2021 -3.967B
September 30, 2021 -1.78B
June 30, 2021 -3.182B
March 31, 2021 -7.295B
December 31, 2020 3.483B
September 30, 2020 -2.587B
June 30, 2020 -993.00M
March 31, 2020 -1.054B
December 31, 2019 -7.677B
September 30, 2019 -941.00M
June 30, 2019 18.27B
March 31, 2019 -2.029B
December 31, 2018 -578.00M
September 30, 2018 -720.00M
Date Value
June 30, 2018 -1.015B
March 31, 2018 -1.222B
December 31, 2017 -1.352B
September 30, 2017 -706.00M
June 30, 2017 -1.006B
March 31, 2017 -1.013B
December 31, 2016 -605.00M
September 30, 2016 -546.00M
June 30, 2016 -552.00M
March 31, 2016 -950.00M
December 31, 2015 -1.359B
September 30, 2015 -700.00M
June 30, 2015 -883.00M
March 31, 2015 -682.00M
December 31, 2014 -231.00M
September 30, 2014 -528.00M
June 30, 2014 -486.00M
March 31, 2014 -1.192B
December 31, 2013 711.00M
September 30, 2013 -620.00M
June 30, 2013 -1.115B
March 31, 2013 -44.00M
December 31, 2012 -958.00M
September 30, 2012 -1.689B
June 30, 2012 -850.00M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-7.677B
Minimum
Dec 2019
14.64B
Maximum
Mar 2024
-2.233B
Average
-3.214B
Median

Cash from Financing (Quarterly) Benchmarks

Johnson & Johnson -9.882B
Eli Lilly and Co 211.30M
Merck & Co Inc -2.425B
Pfizer Inc -4.636B
AbbVie Inc -3.072B